Zachary Moore

1.4k total citations
30 papers, 1.0k citations indexed

About

Zachary Moore is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Zachary Moore has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Toxicology and 5 papers in Organic Chemistry. Recurrent topics in Zachary Moore's work include Bioactive Compounds and Antitumor Agents (10 papers), Cancer therapeutics and mechanisms (8 papers) and Lung Cancer Treatments and Mutations (3 papers). Zachary Moore is often cited by papers focused on Bioactive Compounds and Antitumor Agents (10 papers), Cancer therapeutics and mechanisms (8 papers) and Lung Cancer Treatments and Mutations (3 papers). Zachary Moore collaborates with scholars based in United States, Japan and Australia. Zachary Moore's co-authors include David A. Boothman, Jinming Gao, Gang Huang, Xiuquan Luo, Erik A. Bey, Ying Dong, Haijun Yu, Huabing Chen, Gaurab Chakrabarti and Ralph J. DeBerardinis and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Zachary Moore

27 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zachary Moore United States 14 406 275 214 196 167 30 1.0k
Mahboubeh Rostami Iran 23 437 1.1× 333 1.2× 29 0.1× 438 2.2× 305 1.8× 99 1.5k
Ruirui Zhao China 17 613 1.5× 531 1.9× 30 0.1× 513 2.6× 70 0.4× 34 1.3k
Qianqian Yu China 21 552 1.4× 184 0.7× 18 0.1× 133 0.7× 102 0.6× 37 1.0k
Elaine Amaral Leite Brazil 24 566 1.4× 427 1.6× 28 0.1× 722 3.7× 95 0.6× 60 1.3k
Renata Salgado Fernandes Brazil 22 439 1.1× 371 1.3× 31 0.1× 504 2.6× 69 0.4× 39 1.0k
Kejian Shi China 18 580 1.4× 584 2.1× 21 0.1× 432 2.2× 55 0.3× 35 1.5k
Dae Hwan Shin South Korea 19 386 1.0× 287 1.0× 28 0.1× 444 2.3× 60 0.4× 62 978
Yongseok Choi South Korea 22 566 1.4× 191 0.7× 19 0.1× 144 0.7× 392 2.3× 64 1.3k
Emmanuel O. Akala United States 11 355 0.9× 165 0.6× 21 0.1× 175 0.9× 104 0.6× 26 920
Benny J. Evison Australia 9 262 0.6× 83 0.3× 38 0.2× 123 0.6× 94 0.6× 17 663

Countries citing papers authored by Zachary Moore

Since Specialization
Citations

This map shows the geographic impact of Zachary Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zachary Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zachary Moore more than expected).

Fields of papers citing papers by Zachary Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zachary Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zachary Moore. The network helps show where Zachary Moore may publish in the future.

Co-authorship network of co-authors of Zachary Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Zachary Moore. A scholar is included among the top collaborators of Zachary Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zachary Moore. Zachary Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Lin, Maciej Kmieciak, L. Ashley Cowart, et al.. (2025). Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia. Signal Transduction and Targeted Therapy. 10(1). 50–50. 3 indexed citations
2.
Tringale, Kathryn R., Brandon S. Imber, G. Cederquist, et al.. (2025). Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approach. Frontiers in Oncology. 15. 1511261–1511261.
3.
Moore, Zachary, Xiaojing Huang, Stephanie Lobaugh, et al.. (2024). Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis. Radiotherapy and Oncology. 196. 110320–110320.
4.
Moore, Zachary, et al.. (2023). A pediatric teletrauma program pilot project: Improves access to pediatric trauma care and timely assessment of pediatric traumas. The Journal of Trauma: Injury, Infection, and Critical Care. 97(3). 434–439. 1 indexed citations
5.
Yu, Anthony F., Zachary Moore, Chaya S. Moskowitz, et al.. (2023). Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy–Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast Cancer. JAMA Cardiology. 8(7). 697–697. 7 indexed citations
6.
Shamseddine, A., Zachary Moore, Melody Di Bona, et al.. (2022). Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of Experimental Medicine. 220(3). 15 indexed citations
7.
Moore, Zachary, Andreas Rimner, Stephanie Lobaugh, et al.. (2022). 192P Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis. Annals of Oncology. 33. S118–S118.
8.
Moore, Zachary, A. Shamseddine, Eric Lis, et al.. (2020). Somatic Mutations in Colorectal Cancer Identify Patients at High-risk of Treatment Failure Following Low-BED Spine Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). e572–e573. 1 indexed citations
9.
Moore, Zachary, Jennifer Shah, Lucien Nedzi, et al.. (2019). Risk of Unplanned Hospital Encounters in Patients Treated With Radiotherapy for Head and Neck Squamous Cell Carcinoma. Journal of Pain and Symptom Management. 57(4). 738–745.e3. 19 indexed citations
10.
Sekhar, Praveen Kumar, Zachary Moore, Shyam Aravamudhan, & Ajit Khosla. (2017). A New Low-Temperature Electrochemical Hydrocarbon and NOx Sensor. Sensors. 17(12). 2759–2759. 16 indexed citations
11.
Wang, Miao, Mary Topalovski, Jason E. Toombs, et al.. (2015). Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer. Cancer Research. 75(23). 5058–5069. 36 indexed citations
12.
Chakrabarti, Gaurab, Zachary Moore, Xiuquan Luo, et al.. (2015). Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone. Cancer & Metabolism. 3(1). 12–12. 103 indexed citations
13.
Ma, Xinpeng, Zachary Moore, Gang Huang, et al.. (2015). Nanotechnology-enabled delivery of NQO1 bioactivatable drugs. Journal of drug targeting. 23(7-8). 672–680. 27 indexed citations
14.
Chakrabarti, Gaurab, Molly A. Silvers, Mariya Ilcheva, et al.. (2015). Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. Scientific Reports. 5(1). 17066–17066. 49 indexed citations
15.
Cao, Lifen, Long Shan Li, Ling Xiao, et al.. (2014). Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers. Antioxidants and Redox Signaling. 21(2). 237–250. 32 indexed citations
16.
Ma, Xinpeng, Xiumei Huang, Zachary Moore, et al.. (2014). Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy. Journal of Controlled Release. 200. 201–211. 92 indexed citations
17.
Bey, Erik A., Kathryn E. Reinicke, Melissa C. Srougi, et al.. (2013). Catalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers. Molecular Cancer Therapeutics. 12(10). 2110–2120. 84 indexed citations
18.
Huang, Gang, Huabing Chen, Ying Dong, et al.. (2013). Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy. Theranostics. 3(2). 116–126. 269 indexed citations
19.
Kallen, Alexander J., Joan Brunkard, Zachary Moore, et al.. (2008). Staphylococcus aureus Community-Acquired Pneumonia During the 2006 to 2007 Influenza Season. Annals of Emergency Medicine. 53(3). 358–365. 122 indexed citations
20.
Defloor, Tom, et al.. (2005). EPUAP statement on prevalence and incidence monotoring of pressure ulcer occurrence. Ghent University Academic Bibliography (Ghent University). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahboubeh Rostami Breakdown of academic impact, for papers by Ruirui Zhao Breakdown of academic impact, for papers by Qianqian Yu Breakdown of academic impact, for papers by Elaine Amaral Leite Breakdown of academic impact, for papers by Renata Salgado Fernandes Breakdown of academic impact, for papers by Kejian Shi Breakdown of academic impact, for papers by Dae Hwan Shin Breakdown of academic impact, for papers by Yongseok Choi Breakdown of academic impact, for papers by Emmanuel O. Akala Breakdown of academic impact, for papers by Benny J. Evison
Rankless by CCL
2026